Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study
Sponsor: Ocular Therapeutix, Inc.
Listed as NCT04168112, this PHASE4 trial focuses on Collagen Crosslinking and Keratoconus, Unstable and remains completed. Sponsored by Ocular Therapeutix, Inc., it has been updated 12 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Feb 2024 — Jul 2024 [monthly]
Completed PHASE4
-
May 2023 — Feb 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Nov 2022 — May 2023 [monthly]
Active Not Recruiting PHASE4
▶ Show 7 earlier versions
-
Feb 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE4
-
Dec 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE4
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Feb 2020 — Apr 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ocular Therapeutix, Inc.
- Sight Medical Doctors PLLC
For direct contact, visit the study record on ClinicalTrials.gov .